Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bittam Launches No-KYC Crypto Perpetual Futures Trading with 200x Leverage and ＄100 Deposit Bonus
-
Cyndee Haydon Named Among 2026 Best Real Estate Agents in the United States by RealTrends, Ranking #723 in Florida Out of 232,000 Realtors
-
Are AI Crypto Trading Bots Suitable for Crypto Beginners? BulkQuant Launches an Automated Crypto Trading App
-
SKG Launches PS700 Neck Massager, Bringing Deep Kneading, Layered Heat, and Immersive Audio to Everyday Recovery
-
All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration
-
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress
-
Jura Provides Update on Dutch Attachment Proceedings
-
InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering
-
McFarlane Lake Mining Provides Update on Investor Relations and Marketing Service Engagements
-
Argo Corporation Announces Closing of Strategic Investment
-
SHARE3DCAM Launches AI Engine Algorithm Upgrade in SHARE PointClouds Studio V2.5.0, Advancing the Complete Scan-to-Deliverable Workflow for AEC and Renovation Professionals
-
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
All-Round for Work & Play: KTC Dual-Mode Monitor H27P6 Adapts to Full-Scenario Needs
-
All-Round for Work & Play: KTC Dual-Mode Monitor H27P6 Adapts to Full-Scenario Needs
-
NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials
-
Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (A
-
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
-
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 S
-
Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) wit
-
Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market Growth
-
A.I.S. Resources Announces Grant of Options
-
B2Gold Announces Voting Results from its 2026 Annual General and Special Meeting
-
Knight Announces Early Warning Filing Regarding Shares of Crescita
-
Orca Energy Group Inc. Announces Completion of Q1 2026 Interim Filings
-
Blue Jay Gold Corp. Announces Engagement of Oak Hill Financial Inc. for Investor Relations and Retention of Haywood Securities for Market Making Services
-
Wage gains, retiree benefits highlight Port Colborne Steelworkers’ contract at Vale
-
Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Decrease in May 2026 of 4.1% Compared to 2025
-
Stoneport Advisors Commodity Long Short ETF (SCLS) to Close
-
Vireo Growth Inc. Completes Acquisition of Bridgewell Agribusiness LLC and Plans to Acquire Dispensaries in Nevada and Maryland
-
Fairfax Files Early Warning Report in Respect of Blue Ant Media
-
Crown Point Announces Filing of Final Prospectus and Key Dates for Rights Offering
-
Traction Uranium Announces Extension to Marketing Program
-
Caliber Announces CFO Transition
-
Premier Health of America Announces Grant of Management Cease Trade Order
-
TKROBOTS Launches AI Quant Trading Platform With Free Trial Access for New Users
-
BCB Bancorp, Inc. Announces Inc. Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Century Aluminum to Participate in Wells Fargo Industrials and Materials Conference 2026
-
New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people li
-
dLocal to Report Second Quarter 2026 Financial Results
-
SBA Announces Agency-Wide Reorganization to Modernize, Drive Operational Efficiency, and Enhance Accountability to Taxpayers
-
SalesCloser Enters Global Hospitality Sector and Announces Engagement with Major North American Hotel
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
-
Boralex Obtains Final Court Approval of the Arrangement with Brookfield and La Caisse
-
Banner Health appoints Dr. John Rares Almasan as senior vice president, chief AI, data and infrastructure officer
-
Orange: Continued talks between Altice France group and Bouygues Telecom, Free-iliad Group and Orange
-
Artisan Partners Asset Management Inc. Reports May 2026 Assets Under Management
-
Uniti Group Inc. Announces Pricing of $1.1 Billion Kinetic Fiber Securitization Notes Offering
-
Voting Rights and Shares Capital of the Company
